End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.99 CNY | -8.39% | -7.05% | -27.79% |
Apr. 29 | Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19 | MT |
Sales 2022 | 12.05B 1.66B | Sales 2023 | 1.18B 163M | Capitalization | 13.59B 1.88B |
---|---|---|---|---|---|
Net income 2022 | 5.41B 748M | Net income 2023 | 105M 14.5M | EV / Sales 2022 | 1.54 x |
Net cash position 2022 | 3.33B 460M | Net cash position 2023 | 2.03B 281M | EV / Sales 2023 | 9.78 x |
P/E ratio 2022 |
4.03
x | P/E ratio 2023 |
130
x | Employees | 1,968 |
Yield 2022 |
11.2% | Yield 2023 |
0.15% | Free-Float | 65.64% |
1 day | -8.39% | ||
1 week | -7.05% | ||
Current month | -16.09% | ||
1 month | -16.09% | ||
3 months | -18.25% | ||
6 months | -28.01% | ||
Current year | -27.79% |
Managers | Title | Age | Since |
---|---|---|---|
Luo Huang
CEO | Chief Executive Officer | 44 | 21-05-31 |
Wei Jie Zhang
DFI | Director of Finance/CFO | 53 | 15-03-25 |
Xi Wen Jiang
BRD | Director/Board Member | 42 | 21-06-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zheng Fu Zhu
BRD | Director/Board Member | 60 | 22-05-26 |
Zhe Qiang Xue
CHM | Chairman | 36 | 22-07-03 |
Li Qiang Huang
BRD | Director/Board Member | 57 | 03-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 2 M€ | -15.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 6.99 | -8.39% | 47,805,100 |
24-04-29 | 7.63 | +2.14% | 18,304,320 |
24-04-26 | 7.47 | +0.81% | 11,464,860 |
24-04-25 | 7.41 | +0.27% | 8,135,412 |
24-04-24 | 7.39 | -1.99% | 12,964,490 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-27.79% | 1.36B | |
-18.38% | 56.73M |
- Stock Market
- Equities
- 002030 Stock